Kirjaudu sisään Inderes Free -tilillesi nähdäksesi kaikki sivun maksuton sisältö.

Luo ilmainen tunnus

Hemcheck Sweden

Alle 1K seuraajaa

Kaikki

Tiedotteet

NäytäKaikki sisältötyypit

Pörssitiedote13.11.2024 klo 14.15

Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider

Hemcheck Sweden

Pörssitiedote12.2.2024 klo 12.50

Bio Vitos Pharma AB: KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer

Hemcheck Sweden

Pörssitiedote20.12.2023 klo 6.30

Bio Vitos Pharma AB: The European Patent Office EPO grants patent that is important to Bio Vitos Pharma

Hemcheck Sweden

Liity Inderesin yhteisöön

Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.

FREE-tili

Pörssin suosituin aamukatsaus

Analyytikon kommentit ja suositukset

Osakevertailu

PREMIUM-tili

Kaikki yhtiöraportit ja sisällöt

Premium-työkalut (mm. sisäpiirin kaupat ja screeneri)

Mallisalkku

Luo ilmainen tunnus

Pörssitiedote20.10.2023 klo 14.20

Hemcheck completes the transaction with Bio Vitos

Hemcheck Sweden

Pörssitiedote15.5.2023 klo 13.20

Hemcheck has received a first order from its distributor Astemed

Hemcheck Sweden

Pörssitiedote4.5.2023 klo 12.00

Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement

Hemcheck Sweden

Pörssitiedote26.4.2023 klo 14.20

Hemcheck: Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)

Hemcheck Sweden

Pörssitiedote5.4.2023 klo 20.50

Hemcheck has received a first order from the university hospital Charité in Berlin

Hemcheck Sweden

Pörssitiedote16.3.2023 klo 12.10

Hemcheck: Additional agreement with Bio Vitos Medical brings forward the time for calling the extraordinary general meeting by one week

Hemcheck Sweden

Pörssitiedote13.3.2023 klo 16.00

Hemcheck has received a first follow up order from its Finnish distributor

Hemcheck Sweden

Pörssitiedote2.3.2023 klo 16.00

Hemcheck has received an additional follow up order from its UK distributor

Hemcheck Sweden

Pörssitiedote28.2.2023 klo 20.15

Hemcheck receives follow up order from research program in the United States

Hemcheck Sweden

Pörssitiedote3.2.2023 klo 15.30

Hemcheck has received a follow up order from its French distributor

Hemcheck Sweden

Pörssitiedote1.2.2023 klo 13.30

Hemcheck has received a follow up order from its UK distributor

Hemcheck Sweden

Pörssitiedote24.1.2023 klo 16.00

Hemcheck has received a first order from a leading hospital in Iceland

Hemcheck Sweden

Pörssitiedote23.1.2023 klo 10.00

Hemcheck has received a follow up order from its Spanish distributor

Hemcheck Sweden

Pörssitiedote16.1.2023 klo 21.30

Hemcheck has received another follow up order from its Irish distributor

Hemcheck Sweden

Pörssitiedote3.1.2023 klo 16.27

Hemcheck extends agreement regarding previously communicated project with Region Skåne

Hemcheck Sweden

Pörssitiedote20.12.2022 klo 9.00

Hemcheck has received a follow up order from its Irish distributor

Hemcheck Sweden

Pörssitiedote12.12.2022 klo 14.00

Hemcheck has received an important order from a major OEM

Hemcheck Sweden

Inderesin vastuuvapauslauseke löytyy täältä. Kunkin Inderesin aktiivisessa seurannassa olevan osakkeen tarkemmat tiedot löytyvät kunkin osakkeen omilta yhtiösivuilta Inderes-sivustolla. © Inderes Oyj. Kaikki oikeudet pidätetään.